197 related articles for article (PubMed ID: 22426487)
1. Serum HE4 concentration is not dependent on menstrual cycle or hormonal treatment among endometriosis patients and healthy premenopausal women.
Hallamaa M; Suvitie P; Huhtinen K; Matomäki J; Poutanen M; Perheentupa A
Gynecol Oncol; 2012 Jun; 125(3):667-72. PubMed ID: 22426487
[TBL] [Abstract][Full Text] [Related]
2. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma].
Wang MJ; Qi J; Wang H; Li XX; Wei BJ; Fu C; Gao J; Han BB
Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):540-3. PubMed ID: 22093635
[TBL] [Abstract][Full Text] [Related]
4. Differences in the blood serum levels of soluble HLA-G concentrations between the menstrual cycle phases and menopause in patients with ovarian endometriosis and uterine leiomyoma.
Basta P; Mach P; Pitynski K; Bednarek W; Klimek M; Zietek J; Zajac K; Wicherek L
Neuro Endocrinol Lett; 2009 Mar; 30(1):91-8. PubMed ID: 19300397
[TBL] [Abstract][Full Text] [Related]
5. Comparison of ovarian cancer markers in endometriosis favours HE4 over CA125.
Mckinnon B; Mueller MD; Nirgianakis K; Bersinger NA
Mol Med Rep; 2015 Oct; 12(4):5179-84. PubMed ID: 26165164
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward?
Azzam AZ; Hashad DI; Kamel NA
Arch Gynecol Obstet; 2013 Jul; 288(1):167-72. PubMed ID: 23361457
[TBL] [Abstract][Full Text] [Related]
7. Comparison between Serum HE4 and CA125 as Tumor Markers in Premenopausal Women with Benign Pelvic Mass.
Huang X; Wang Y; He X; Kang F; Luo L; Su Z; Ye H
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115211
[TBL] [Abstract][Full Text] [Related]
8. [Clinical value of combined detection of serum human epididymal secretory protein E4 and CA(125) in the diagnosis of endometrial carcinoma].
Zhang AM; Zhang P
Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):125-8. PubMed ID: 22455745
[TBL] [Abstract][Full Text] [Related]
9. Use of CA125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary report.
Kafali H; Artuc H; Demir N
Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):85-8. PubMed ID: 15294374
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of HE4 change little during in vitro fertilization.
Hallamaa M; Huhtinen K; Suvitie P; Perheentupa A
Acta Obstet Gynecol Scand; 2014 Jul; 93(7):640-6. PubMed ID: 24734893
[TBL] [Abstract][Full Text] [Related]
11. [Measurement of serum human epididymis secretory protein 4 combined with CA125 assay in differential diagnosis of endometriosis cyst and ovarian benign and malignant tumors].
Liu YN; Ye X; Cheng HY; Cheng YX; Fu TY; Chen J; Chang XH; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2010 May; 45(5):363-6. PubMed ID: 20646446
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of erythrocyte band 3 phosphotyrosine level, glutathione content, CA-125, and human epididymal secretory protein E4 as combined parameters in endometriosis.
Bordin L; Fiore C; Donà G; Andrisani A; Ambrosini G; Faggian D; Plebani M; Clari G; Armanini D
Fertil Steril; 2010 Oct; 94(5):1616-21. PubMed ID: 20153468
[TBL] [Abstract][Full Text] [Related]
13. Is HE4 a useful endometrioma marker?
Leggieri C; D'Agostino G; Tommasi L; Plebani M; Conte L
Eur J Gynaecol Oncol; 2014; 35(4):438-41. PubMed ID: 25118488
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of the combined detection of serum Smac, HE4 and CA125 in endometriosis-associated ovarian cancer.
Xu XR; Wang X; Zhang H; Liu MY; Chen Q
Cancer Biomark; 2018 Feb; 21(2):471-477. PubMed ID: 29226858
[TBL] [Abstract][Full Text] [Related]
15. CA125 and HE4 levels in a Czech female population diagnosed with endometrial cancer in preoperative management.
Presl J; Novotny Z; Topolcan O; Vlasak P; Kucera R; Fuchsova R; Vrzalova J; Betincova L; Svobodova S
Anticancer Res; 2014 Jan; 34(1):327-31. PubMed ID: 24403483
[TBL] [Abstract][Full Text] [Related]
16. The effect of the phase of the menstrual cycle and the birth control pill on athletic performance.
Lebrun CM
Clin Sports Med; 1994 Apr; 13(2):419-41. PubMed ID: 8013042
[TBL] [Abstract][Full Text] [Related]
17. [HE4--a new tumor marker for ovarian cancer].
Manolov V; Marinov B; Vasilev V; Andreeva A
Akush Ginekol (Sofiia); 2011; 50 Suppl 2():11-5. PubMed ID: 22524132
[TBL] [Abstract][Full Text] [Related]
18. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561
[TBL] [Abstract][Full Text] [Related]
19. Alterations in RCAS1 serum concentration levels during the normal menstrual cycle and the lack of analogical changes in ovarian endometriosis.
Wicherek L
Am J Reprod Immunol; 2008 Jun; 59(6):535-44. PubMed ID: 18422812
[TBL] [Abstract][Full Text] [Related]
20. Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women.
Holcomb K; Vucetic Z; Miller MC; Knapp RC
Am J Obstet Gynecol; 2011 Oct; 205(4):358.e1-6. PubMed ID: 21722869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]